Format

Send to:

Choose Destination
See comment in PubMed Commons below
Lancet. 2007 Apr 21;369(9570):1379-90.

Ankylosing spondylitis.

Author information

  • 1Ruhr-Universit├Ąt Bochum, Rheumazentrum Ruhrgebiet, 44652 Herne, Germany. j.braun@rheumazentrum-ruhrgebiet.de

Abstract

Ankylosing spondylitis is a common inflammatory rheumatic disease that affects the axial skeleton, causing characteristic inflammatory back pain, which can lead to structural and functional impairments and a decrease in quality of life. New imaging techniques and therapies have substantially changed the management of this disease in the past decade. Whether inhibition of radiographic progression and structural damage can be reached with available drugs is as yet unclear. Furthermore, treatment with non-steroidal anti-inflammatory agents and physiotherapy remains an important approach to long-term management of patients with ankylosing spondylitis. The new treatment options with tumour necrosis factor blockers seems a breakthrough for patients refractory to conventional treatment.

PMID:
17448825
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk